Cargando…
Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
BACKGROUND: Hepsin, (also called TMPRSS1) and TMPRSS3 are type II transmembrane serine proteases (TTSPs) that are involved in cancer progression. TTSPs can remodel extracellular matrix (ECM) and, when dysregulated, promote tumor progression and metastasis by inducing defects in basement membrane and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445813/ https://www.ncbi.nlm.nih.gov/pubmed/26014348 http://dx.doi.org/10.1186/s12885-015-1440-5 |
_version_ | 1782373332790804480 |
---|---|
author | Pelkonen, Mikko Luostari, Kaisa Tengström, Maria Ahonen, Hermanni Berdel, Bozena Kataja, Vesa Soini, Ylermi Kosma, Veli-Matti Mannermaa, Arto |
author_facet | Pelkonen, Mikko Luostari, Kaisa Tengström, Maria Ahonen, Hermanni Berdel, Bozena Kataja, Vesa Soini, Ylermi Kosma, Veli-Matti Mannermaa, Arto |
author_sort | Pelkonen, Mikko |
collection | PubMed |
description | BACKGROUND: Hepsin, (also called TMPRSS1) and TMPRSS3 are type II transmembrane serine proteases (TTSPs) that are involved in cancer progression. TTSPs can remodel extracellular matrix (ECM) and, when dysregulated, promote tumor progression and metastasis by inducing defects in basement membrane and ECM molecules. This study investigated whether the gene and protein expression levels of these TTSPs were associated with breast cancer characteristics or survival. METHODS: Immunohistochemical staining was used to evaluate hepsin levels in 372 breast cancer samples and TMPRSS3 levels in 373 samples. TMPRSS1 mRNA expression was determined in 125 invasive and 16 benign breast tumor samples, and TMPRSS3 mRNA expression was determined in 167 invasive and 23 benign breast tumor samples. The gene and protein expression levels were analyzed for associations with breast cancer-specific survival and clinicopathological parameters. RESULTS: Low TMPRSS1 and TMPRSS3 mRNA expression levels were independent prognostic factors for poor breast cancer survival during the 20-year follow-up (TMPRSS1, P = 0.023; HR, 2.065; 95 % CI, 1.106–3.856; TMPRSS3, P = 0.013; HR, 2.106; 95 % CI, 1.167–3.800). Low expression of the two genes at the mRNA and protein levels associated with poorer survival compared to high levels (log rank P-values 0.015–0.042). Low TMPRSS1 mRNA expression was also an independent marker of poor breast cancer prognosis in patients treated with radiotherapy (P = 0.034; HR, 2.344; 95 % CI, 1.065–5.160). Grade III tumors, large tumor size, and metastasis were associated with low mRNA and protein expression levels. CONCLUSIONS: The results suggest that the TTSPs hepsin and TMPRSS3 may have similar biological functions in the molecular pathology of breast cancer. Low mRNA and protein expression levels of the studied TTSPs were prognostic markers of poor survival in breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1440-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4445813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44458132015-05-28 Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival Pelkonen, Mikko Luostari, Kaisa Tengström, Maria Ahonen, Hermanni Berdel, Bozena Kataja, Vesa Soini, Ylermi Kosma, Veli-Matti Mannermaa, Arto BMC Cancer Research Article BACKGROUND: Hepsin, (also called TMPRSS1) and TMPRSS3 are type II transmembrane serine proteases (TTSPs) that are involved in cancer progression. TTSPs can remodel extracellular matrix (ECM) and, when dysregulated, promote tumor progression and metastasis by inducing defects in basement membrane and ECM molecules. This study investigated whether the gene and protein expression levels of these TTSPs were associated with breast cancer characteristics or survival. METHODS: Immunohistochemical staining was used to evaluate hepsin levels in 372 breast cancer samples and TMPRSS3 levels in 373 samples. TMPRSS1 mRNA expression was determined in 125 invasive and 16 benign breast tumor samples, and TMPRSS3 mRNA expression was determined in 167 invasive and 23 benign breast tumor samples. The gene and protein expression levels were analyzed for associations with breast cancer-specific survival and clinicopathological parameters. RESULTS: Low TMPRSS1 and TMPRSS3 mRNA expression levels were independent prognostic factors for poor breast cancer survival during the 20-year follow-up (TMPRSS1, P = 0.023; HR, 2.065; 95 % CI, 1.106–3.856; TMPRSS3, P = 0.013; HR, 2.106; 95 % CI, 1.167–3.800). Low expression of the two genes at the mRNA and protein levels associated with poorer survival compared to high levels (log rank P-values 0.015–0.042). Low TMPRSS1 mRNA expression was also an independent marker of poor breast cancer prognosis in patients treated with radiotherapy (P = 0.034; HR, 2.344; 95 % CI, 1.065–5.160). Grade III tumors, large tumor size, and metastasis were associated with low mRNA and protein expression levels. CONCLUSIONS: The results suggest that the TTSPs hepsin and TMPRSS3 may have similar biological functions in the molecular pathology of breast cancer. Low mRNA and protein expression levels of the studied TTSPs were prognostic markers of poor survival in breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1440-5) contains supplementary material, which is available to authorized users. BioMed Central 2015-05-27 /pmc/articles/PMC4445813/ /pubmed/26014348 http://dx.doi.org/10.1186/s12885-015-1440-5 Text en © Pelkonen et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Pelkonen, Mikko Luostari, Kaisa Tengström, Maria Ahonen, Hermanni Berdel, Bozena Kataja, Vesa Soini, Ylermi Kosma, Veli-Matti Mannermaa, Arto Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival |
title | Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival |
title_full | Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival |
title_fullStr | Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival |
title_full_unstemmed | Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival |
title_short | Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival |
title_sort | low expression levels of hepsin and tmprss3 are associated with poor breast cancer survival |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445813/ https://www.ncbi.nlm.nih.gov/pubmed/26014348 http://dx.doi.org/10.1186/s12885-015-1440-5 |
work_keys_str_mv | AT pelkonenmikko lowexpressionlevelsofhepsinandtmprss3areassociatedwithpoorbreastcancersurvival AT luostarikaisa lowexpressionlevelsofhepsinandtmprss3areassociatedwithpoorbreastcancersurvival AT tengstrommaria lowexpressionlevelsofhepsinandtmprss3areassociatedwithpoorbreastcancersurvival AT ahonenhermanni lowexpressionlevelsofhepsinandtmprss3areassociatedwithpoorbreastcancersurvival AT berdelbozena lowexpressionlevelsofhepsinandtmprss3areassociatedwithpoorbreastcancersurvival AT katajavesa lowexpressionlevelsofhepsinandtmprss3areassociatedwithpoorbreastcancersurvival AT soiniylermi lowexpressionlevelsofhepsinandtmprss3areassociatedwithpoorbreastcancersurvival AT kosmavelimatti lowexpressionlevelsofhepsinandtmprss3areassociatedwithpoorbreastcancersurvival AT mannermaaarto lowexpressionlevelsofhepsinandtmprss3areassociatedwithpoorbreastcancersurvival |